CSG's Capital Discipline Question Overshadows a Defence Group in Overdrive
Published on 08/09/2026 at 18:52 | Redaktion boerse-global.de
The arithmetic of CSG's latest trading session looks jarring at first glance. A defence contractor that just posted double-digit revenue growth and reaffirmed its full-year guidance watched its shares shed 6.88% on Friday, closing at €18.10. Yet the sell-off says less about the underlying business than about the gap between where the company's balance sheet stands today and where management insists it will be by year-end.
Zoom out, and the picture shifts dramatically. The stock remains up 28.37% over the past month, a rally that has only partially unwound. Even after Friday's drop, the shares trade roughly half below their 52-week high of €36.05, reached back in January.
The Working Capital Conundrum
The crux of investor unease is tied-up operating capital. CSG currently carries working capital equivalent to 40% of revenue — a figure the company itself has pledged to cut below 20% by the end of the year. That is an ambitious trajectory, and the market's scepticism is understandable: the gap between current reality and the stated target is substantial.
The company's own numbers illustrate the tension. In the first half of 2026, revenue climbed to €3.3 billion, with operating EBIT up 13% at €784 million and an EBIT margin of 24.1% — comfortably inside the guided range. But a deliberate build-up of component inventories, particularly in medium-calibre ammunition, has weighed on the balance sheet. Management expects to release €1.5 billion of that trapped working capital in the second half.
When operations scale up as quickly as CSG's, the supporting processes often struggle to keep pace — and the same is true in any industrial workplace. Many employers underestimate how easily a fast-moving production environment can outgrow its safety documentation. A free toolkit with 41 ready-to-use templates and checklists helps you document workplace risks properly and stay on top of compliance as your operations grow. Download the free Risk Assessment Toolkit
Net debt stood at €2,914 million, equivalent to 1.6 times trailing twelve-month operating EBITDA. The target is to bring that ratio below 1.3 by year-end. A €3.06 billion credit facility provides additional headroom, offering the group the flexibility to unwind its working capital position without operational strain.
Cash conversion, meanwhile, runs between 80% and 86% — respectable, but it also signals that a meaningful slice of earnings remains tied up in receivables and inventory before converting into actual cash flow.
An Order Book That Keeps Growing
The demand side of the equation remains emphatically strong. The order book has swelled to €46 billion, with a book-to-bill ratio of 1.5 — for every euro of revenue, the group books one and a half euros of new orders. That metric points to sustained demand well beyond the current fiscal year.
Second-quarter figures underscore the momentum: revenue reached €1.707 billion, an 18% increase over the €1.443 billion posted in the same period a year earlier. The full-year outlook of €7.4 billion to €7.6 billion in revenue with an EBIT margin between 24% and 25% was reaffirmed.
Geographically, Europe excluding Ukraine accounts for more than half of sales, with the US the second-largest market. The Ukraine share of total revenue has fallen from 27% to 17%, reflecting the growing weight of NATO markets in the mix. Land Systems has been the standout performer, with revenue doubling year-on-year and now representing 46% of the €17 billion order book. Majority owner Michal Strnad struck a confident tone, citing robust demand heading into the second half.
A Leadership Blitz and Strategic Expansion
The operational story is matched by a concerted effort to bolster the executive bench. Ben Hudson joined the supervisory board as member and vice-chair on August 1, having already arrived at the group in June as CEO of CSG Land Systems and Group Chief Technology Officer. He follows a series of high-profile hires this year, including Jason Monahan, formerly of GDLS-Canada and General Dynamics, and Thomas Berge Nielsen, previously CEO of Rheinmetall's Global Business division. Additional recruits have come from Northrop Grumman, Raytheon, J.P. Morgan, and competitors including KNDS, BAE Systems and German munitions maker RWS.
The management overhaul runs alongside a string of strategic moves. On Wednesday, CSG took a stake in Canadian defence technology firm North Vector Dynamics, which focuses on air defence systems, precision-guided munitions, counter-drone technology and next-generation hypersonics. The investment amount was not disclosed, though the company said North Vector's valuation now exceeds US$90 million.
A day earlier, CSG finalised the acquisition of a 57-hectare industrial site in Gnaschwitz, Saxony, near Bautzen, from MAXAM. The group plans to invest more than €100 million in production capacity for nitroglycerin and nitroglycerin-based products, alongside munitions and component manufacturing. Up to 125 jobs are expected to be created.
Scaling up production of hazardous substances like nitroglycerin brings serious legal responsibilities — and many companies overlook just how much documentation is required. Under UK COSHH regulations, you have a legal duty to assess and control risks from dangerous substances in your workplace. A free toolkit with 43 customisable templates, checklists and toolbox talks helps you meet those obligations without hours of paperwork. Get the free COSHH Toolkit
These moves fit a broader strategy of vertical integration that CSG aims to complete by the end of 2027. By end-2026, 60% of long-range ammunition should be produced in-house, and tank production under the Karpat name is slated to begin in the first quarter of 2027.
The Quarter That Matters
For all the strategic noise, the decisive question for investors remains whether the promised working capital release actually materialises. The management has set itself a clear target, and the second half of 2026 will determine whether the market's patience is rewarded. Until then, the elevated share price volatility of recent weeks is likely to persist — the gap between a booming order book and a balance sheet still digesting its own growth is not one the market will close on faith alone.
